Prime Medicine, Inc.
USD3.72
+0.29 (+8.45%)
CEO
Allan Reine
IPO Date
2022-10-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.74
Prev. Close
$3.43
Day Low
$3.58
Day High
$3.94
52W Low
$2.28
52W High
$6.94
Market Cap
$0.67B
Volume
5.25M
| 75,000 |
| $3.06 |
| 8 Jun 2026 | NELSEN ROBERT | director, 10 percent owner: | A-Award | Acquired | 75,000 | $3.06 |
| 8 Jun 2026 | Kelly Michael Aaron | director | A-Award | Acquired | 75,000 | $3.06 |
| 8 Jun 2026 | Foster-Cheek Kaye I | director | A-Award | Acquired | 75,000 | $3.06 |
| 8 Jun 2026 | Chung Wendy | director | A-Award | Acquired | 75,000 | $3.06 |
| 8 Jun 2026 | Cahill Thomas | director | A-Award | Acquired | 75,000 | $3.06 |
| 17 Apr 2026 | Makhni Svetlana Ni | Chief Financial Officer | A-Award | Acquired | 800,000 | $3.67 |
| 17 Apr 2026 | Makhni Svetlana Ni | officer | Disposed | 0 | $0.00 |
| 27 Feb 2026 | Reine Allan | director, officer: Chief Executive Officer | A-Award | Acquired | 1,300,000 | $4.38 |